129 related articles for article (PubMed ID: 21159249)
21. Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression.
Gao Z; Yuan T; Zhou X; Ni P; Sun G; Li P; Cheng Z; Wang X
Cancer Biol Ther; 2018 May; 19(5):407-415. PubMed ID: 29333921
[TBL] [Abstract][Full Text] [Related]
22. Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells.
Thumma SC; Jacobson BA; Patel MR; Konicek BW; Franklin MJ; Jay-Dixon J; Sadiq A; De A; Graff JR; Kratzke RA
Cancer Gene Ther; 2015 Aug; 22(8):396-401. PubMed ID: 26227824
[TBL] [Abstract][Full Text] [Related]
23. [Over-expressions of p-eIF4E and p-4EBP1 are associated with poor prognosis in nasopharyngeal carcinoma].
Zheng J; Zhang C; Zhang Y; Pei J; Fan S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Apr; 33(4):531-535. PubMed ID: 28395726
[TBL] [Abstract][Full Text] [Related]
24. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD
Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
[TBL] [Abstract][Full Text] [Related]
25. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
[TBL] [Abstract][Full Text] [Related]
26. eIF4E Overexpression Is Associated with Poor Prognoses of Ovarian Cancer.
Zheng J; Li X; Zhang C; Zhang Y
Anal Cell Pathol (Amst); 2020; 2020():8984526. PubMed ID: 33489719
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo.
Fang D; Peng J; Wang G; Zhou D; Geng X
Int J Mol Med; 2019 Oct; 44(4):1325-1332. PubMed ID: 31432159
[TBL] [Abstract][Full Text] [Related]
28. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
[TBL] [Abstract][Full Text] [Related]
29. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
Liao DW; Wang L; Zhang XG; Liu MQ
Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
[TBL] [Abstract][Full Text] [Related]
30. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
32. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
Sorrells DL; Meschonat C; Black D; Li BD
J Surg Res; 1999 Jul; 85(1):37-42. PubMed ID: 10383835
[TBL] [Abstract][Full Text] [Related]
33. [Clinical significance of the expression of eukaryotic initiation factor 4 E and mammalian target of rapamycin in esophageal squamous carcinoma tissues].
Lu J; Pan Y; Lei Y; Gu Y; Zhong F
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):905-8. PubMed ID: 26404688
[TBL] [Abstract][Full Text] [Related]
34. mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.
Ferrandiz-Pulido C; Masferrer E; Toll A; Hernandez-Losa J; Mojal S; Pujol RM; Ramon y Cajal S; de Torres I; Garcia-Patos V
J Urol; 2013 Dec; 190(6):2288-95. PubMed ID: 23764082
[TBL] [Abstract][Full Text] [Related]
35. TLK1B is elevated with eIF4E overexpression in breast cancer.
Norton KS; McClusky D; Sen S; Yu H; Meschonat C; Debenedetti A; Li BD
J Surg Res; 2004 Jan; 116(1):98-103. PubMed ID: 14732354
[TBL] [Abstract][Full Text] [Related]
36. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer.
McClusky DR; Chu Q; Yu H; Debenedetti A; Johnson LW; Meschonat C; Turnage R; McDonald JC; Abreo F; Li BD
Ann Surg; 2005 Oct; 242(4):584-90; discussion 590-2. PubMed ID: 16192819
[TBL] [Abstract][Full Text] [Related]
37. The expression of proto-oncogene eIF4E in laryngeal squamous cell carcinoma.
Liang Z; Lei T; LuYing Z; YuPing G
Laryngoscope; 2003 Jul; 113(7):1238-43. PubMed ID: 12838026
[TBL] [Abstract][Full Text] [Related]
38. Positive Correlative over-Expression between eIF4E and Snail in Nasopharyngeal Carcinoma Promotes its Metastasis and Resistance to Cisplatin.
Yao Y; Pang T; Cheng Y; Yong W; Kang H; Zhao Y; Wang S; Hu X
Pathol Oncol Res; 2020 Jul; 26(3):1639-1649. PubMed ID: 31512056
[TBL] [Abstract][Full Text] [Related]
39. Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.
Han B; Zhang Q; Li G; Zhang R; Li H
Med Sci Monit; 2019 Oct; 25():7936-7941. PubMed ID: 31641096
[TBL] [Abstract][Full Text] [Related]
40. [Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].
Weng MX; Wu CH; Yang XP
Ai Zheng; 2008 Feb; 27(2):191-5. PubMed ID: 18279620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
